DE3785312T2 - Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel. - Google Patents

Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel.

Info

Publication number
DE3785312T2
DE3785312T2 DE8787118083T DE3785312T DE3785312T2 DE 3785312 T2 DE3785312 T2 DE 3785312T2 DE 8787118083 T DE8787118083 T DE 8787118083T DE 3785312 T DE3785312 T DE 3785312T DE 3785312 T2 DE3785312 T2 DE 3785312T2
Authority
DE
Germany
Prior art keywords
tetrahydropyridinoxime
cholinergic
medicines
substituted
substituted tetrahydropyridinoxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787118083T
Other languages
English (en)
Other versions
DE3785312D1 (de
Inventor
Stephen Clark Bergmeier
David Alexis Downs
Walter Hamilton Moos
David Winslow Moreland
Haile Tecle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/939,507 external-priority patent/US4710508A/en
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE3785312D1 publication Critical patent/DE3785312D1/de
Application granted granted Critical
Publication of DE3785312T2 publication Critical patent/DE3785312T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE8787118083T 1986-12-08 1987-12-07 Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel. Expired - Fee Related DE3785312T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/939,507 US4710508A (en) 1986-12-08 1986-12-08 O-substituted tetrahydropyridine oxime cholinergic agents
US07/091,893 US4786648A (en) 1986-12-08 1987-09-04 O-substituted tetrahydropyridine oxime cholinergic agents

Publications (2)

Publication Number Publication Date
DE3785312D1 DE3785312D1 (de) 1993-05-13
DE3785312T2 true DE3785312T2 (de) 1993-07-22

Family

ID=26784455

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787118083T Expired - Fee Related DE3785312T2 (de) 1986-12-08 1987-12-07 Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel.

Country Status (11)

Country Link
US (1) US4786648A (de)
EP (1) EP0271798B1 (de)
KR (1) KR960000072B1 (de)
AU (1) AU607442B2 (de)
DE (1) DE3785312T2 (de)
DK (1) DK638487A (de)
FI (1) FI85467C (de)
NO (1) NO172045C (de)
NZ (1) NZ222756A (de)
PH (1) PH23404A (de)
PT (1) PT86311B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
US5219873A (en) * 1987-04-24 1993-06-15 Roussel Uclaf Compounds of 1,2,5,6-tetrahydropyridine which are useful as cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
US5231107A (en) * 1987-08-21 1993-07-27 Roussel Uclaf Derivatives of the oxime of 1,2,5,6-tetrahydropyridine 3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
IT1222526B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
DK177889A (da) * 1988-04-15 1989-10-16 Beecham Group Plc Hidtil ukendte forbindelser
US5278170A (en) * 1989-04-13 1994-01-11 Beecham Group P.L.C. Azabicylo oxime compounds
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
IT1240603B (it) * 1990-03-14 1993-12-17 Roussel Maestretti Spa Derivati della 1,2,5,6-tetraidropiridina 3- carbossaldeide ossima, loro procedimento di preparazione e loro impiego come sostanza medicinale
IT1241138B (it) * 1990-05-15 1993-12-29 Roussel Pharma Derivati dell'ossina della 1,2,5,6- tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IE912974A1 (en) * 1990-08-24 1992-02-26 Beecham Group Plc Novel compounds
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
WO1992006959A1 (en) * 1990-10-12 1992-04-30 Beecham Group Plc 1,2,5,6-tetrahydropyridine oxime derivatives
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
AU3142793A (en) * 1991-12-18 1993-07-19 Warner-Lambert Company Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia
ZA931109B (en) * 1992-03-04 1993-09-22 Akzo Nv Tetrahydropyrimidine derivatives.
US5208343A (en) * 1992-03-24 1993-05-04 Warner-Lambert Company Tetrahydropyridine oxime compounds
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
WO1994007493A1 (en) * 1992-10-06 1994-04-14 Warner-Lambert Company Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime
AU5628194A (en) * 1992-11-27 1994-06-22 Akzo N.V. 1,3-diazacycloalkyl oxime derivatives
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
US5618818A (en) * 1996-03-20 1997-04-08 The University Of Toledo Muscarinic agonist compounds
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2004101422A2 (en) * 2003-05-13 2004-11-25 Oasis Corporation Combined water cooler and refrigerator unit
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2007075297A2 (en) * 2005-12-27 2007-07-05 University Of Toledo Muscarinic agonists and methods of use thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889074A (en) * 1959-02-12 1962-02-07 Ciba Ltd New pyridine derivatives and process for their manufacture
FR1258847A (fr) * 1960-02-12 1961-04-21 Ciba Geigy Procédé de préparation de nouveaux dérivés pyridiniques, entre autres de l'oxime de la l-méthyl-3 ou 4-acétyl-1, 2, 5, 6-tétrahydropyridine
JPS511638A (ja) * 1974-06-27 1976-01-08 Fujisawa Pharmaceutical Co Shokubutsuseichochoseizai
US4297359A (en) * 1978-07-25 1981-10-27 Acf Chemiefarma Nv Anti-ulcer compositions containing certain pyridyl oxime ethers
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti

Also Published As

Publication number Publication date
PH23404A (en) 1989-07-26
DE3785312D1 (de) 1993-05-13
FI85467C (fi) 1992-04-27
NO172045C (no) 1993-06-02
KR880007466A (ko) 1988-08-27
NO172045B (no) 1993-02-22
NO875082L (no) 1988-06-09
PT86311B (pt) 1990-11-07
FI875363A (fi) 1988-06-09
AU607442B2 (en) 1991-03-07
AU8110287A (en) 1988-06-09
EP0271798B1 (de) 1993-04-07
DK638487A (da) 1988-06-09
NO875082D0 (no) 1987-12-07
DK638487D0 (da) 1987-12-04
NZ222756A (en) 1989-10-27
EP0271798A3 (en) 1989-01-18
EP0271798A2 (de) 1988-06-22
PT86311A (en) 1988-01-01
US4786648A (en) 1988-11-22
FI875363A0 (fi) 1987-12-04
FI85467B (fi) 1992-01-15
KR960000072B1 (ko) 1996-01-03

Similar Documents

Publication Publication Date Title
DE3785312T2 (de) Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel.
DE69009822D1 (de) Zusammensetzung und ihre Verwendung.
DE3787590D1 (de) Polytetrafluoraethylenhaltige beschichtungsmasse und ihre verwendung.
DE3871751T2 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE3873797T2 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
FI860380A0 (fi) Foerfarande foer bildning av i realtid varande reglerparametrar medelst videokamera vid roekgenererande foerbraenningsreaktioner.
DE3879811T2 (de) Pharmazeutische Zusammensetzung und ihre Verwendung.
DE3776962D1 (de) Lichtempfindliche harzzusammensetzung und ihre verwendung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE3688369T2 (de) Nodulationsfoerdernde bakterien und ihre verwendung.
DE3887417T2 (de) Thienocinnolinverbindungen und deren verwendung als heilmittel.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE3761138D1 (de) Nitratderivate und ihre verwendung als gefaesserweiterer.
DE68919154D1 (de) Benzodiazepinverbindungen und ihre Verwendung als Arzneimittel.
DE3875877D1 (de) Phthalocyaninverbindungen und ihre verwendung.
DE69009204D1 (de) Hydroxyperoxide und ihre Verwendung.
DE3883352T2 (de) Muramylpeptid-Derivate und ihre Verwendung.
DE3886599D1 (de) Thiophen-2-carboxamid-Derivate und ihre Verwendung als Pharmaka.
DE3888608T2 (de) Einbettzusammensetzung und ihre Verwendung.
ATE125534T1 (de) Substituierte dibenzonfurane und ihre verwendung.
ATE87912T1 (de) Substituierte tetrahydropyridinoxime und ihre verwendung als cholinergische heilmittel.
DE3767084D1 (de) Dipropargyloxybenzolverbindungen und ihre herstellung.
ATE66218T1 (de) 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee